Glen Harbor Capital Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$41.2M Sell
194,920
-1,232
-0.6% -$257K 0.86% 24
2019
Q2
$38.1M Buy
196,152
+15,818
+9% +$2.92M 0.79% 26
2019
Q1
$29.7M Buy
180,334
+8,734
+5% +$1.54M 0.64% 37
2018
Q4
$32.3M Sell
171,600
-9,240
-5% -$1.71M 0.78% 27
2018
Q3
$30.8M Buy
180,840
+4,246
+2% +$715K 0.62% 31
2018
Q2
$28.9M Buy
176,594
+1,826
+1% +$298K 0.62% 34
2018
Q1
$28.3M Sell
174,768
-14,982
-8% -$2.38M 0.64% 34
2017
Q4
$27.7M Sell
189,750
-11,660
-6% -$1.66M 0.63% 37
2017
Q3
$27.3M Sell
201,410
-8,734
-4% -$1.1M 0.65% 34
2017
Q2
$26.3M Sell
210,144
-6,688
-3% -$800K 0.64% 37
2017
Q1
$25.8M Sell
216,832
-10,120
-4% -$1.22M 0.64% 39
2016
Q4
$26.2M Buy
+226,952
New +$25.3M 0.71% 36

Other funds holding CME

Glen Harbor Capital Management's CME Position: Q3 2019 in Review

Glen Harbor Capital Management reduced its CME Group (CME) stake by 0.63% in Q3 2019, selling an estimated $257K and leaving 194,920 shares worth $41.2M. The position accounts for 0.86% of the portfolio, ranked #24.

Glen Harbor Capital Management first reported a position in CME in Q4 2016 and has held it in 12 quarters since. 992 funds tracked by Wall St. Rank hold CME as of Q3 2019.

  • Glen Harbor Capital Management held 194,920 shares of CME Group worth $41.2M as of Q3 2019.
  • Glen Harbor Capital Management sold 1,232 CME Group shares in Q3 2019, an estimated $257K.
  • CME Group made up 0.86% of Glen Harbor Capital Management's portfolio in Q3 2019, its #24 holding.
  • Glen Harbor Capital Management first reported a position in CME Group in Q4 2016 and has held it in 12 quarters since.
  • 992 funds tracked by Wall St. Rank held CME Group as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.